Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
English
|
|||||||||
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_AnnouncementContentSection|
|
|
||||||||
oda_ExplanationSection|
|
|
||||||||
oda_ExplanationTextBlock|
|
MLP Care issues a floating rate commercial bond with the nominal value of TL150.000.000, maturity date of 2021 (350 days), compound interest rate of %16.7666, %16.7711, and %16.7711 for the first 3 months respectively (calculated with 3 months TRLibor + 450 basis points), ISIN code TRFMLPCA2017, on December 20th, 2019. The bond is sold solely to the qualified institutional investors. The coupon rates between 4th and 12th months will be calculated with the same floating rate method. The recent bond has been issued i) to refinance the prior bond, with the nominal value of TL 64,340,000, maturity date of December 20th, 2019 (179 days), 33.1894% compound interest rates, ii) to replace working capital rotative credit lines with higher interest rates, and iii) to finance new hospital openings. Therefore, MLP Care extends the maturity and decreases the cost of borrowing significantly by taking advantage of the improvement in financing conditions in Turkey. The bond issue has been performed in line with the CMB's approval dated August 8th, 2019 and numbered 44/1021 to the issue ceiling of up to TL 500,000,000. The beginning date of the bond is December 20th, 2019. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.